Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alex Denner
Pharma
Alkermes shareholders reject 3 board nominees from Sarissa
Shareholders in Alkermes have quelled Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor.
Kevin Dunleavy
Jun 30, 2023 10:50am
Alkermes lets shareholder Sarissa picks its next board director
May 3, 2021 10:38am
Ironwood names Alex Denner to its board after R&D spinoff
Nov 9, 2020 12:27pm
Did Biogen learn a big lesson from its past proxy fights?
Apr 29, 2019 11:02am
Ironwood lets go of 40 staffers in preparation for R&D split
Jul 5, 2018 12:05pm
Activist Denner, favoring Ironwood's R&D spin, backs off
Jun 1, 2018 12:30pm
